Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Miyoshi

Showing results (81-90 of 178) with videos related to

Pageof 18
Sort By:
Breast Cancer (Tokyo, Japan)|April 5, 2016
Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastasesArisa Nishimukai, Tomoko Higuchi, Hiromi Ozawa, et al.
EJNMMI Research|January 25, 2021
Preliminary study of AI-assisted diagnosis using FDG-PET/CT for axillary lymph node metastasis in patients with breast cancerZongyao Li, Kazuhiro Kitajima, Kenji Hirata, et al.
Journal of Surgical Oncology|June 25, 2018
High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapyYukie Fujimoto, Tomoko Higuchi, Arisa Nishimukai, et al.
Breast Cancer Research and Treatment|October 14, 2024
The cytokine profile correlates with less tumor-infiltrating lymphocytes in luminal A breast cancerEri Ishikawa, Takahiro Watanabe, Takako Kihara, et al.
Anticancer Research|May 23, 2002
uPA receptor expression in benign and malignant thyroid tumorsSeung Jin Kim, Eiichi Shiba, Tetsuya Taguchi, et al.
Anticancer Research|January 31, 2025
Clinical Utility of Sentinel Lymph Node Biopsy Using the Medical Imaging Projection System in Breast Cancer Patients, Including Those Following Neoadjuvant ChemotherapyAoi Oshiro, Masayuki Nagahashi, Yusa Togashi, et al.
European Journal of Radiology|December 21, 2022
Relationship between FDG-PET and the immune microenvironment in breast cancerKazuhiro Kitajima, Tomoko Higuchi, Yukie Fujimoto, et al.
Anticancer Research|July 5, 2020
C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With EribulinAtsushi Sata, Reiko Fukui, Yoshimasa Miyagawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Prognostic significance of CD55 expression in breast cancerJun-Ichiro Ikeda, Eiichi Morii, Yalan Liu, et al.
Breast Cancer (Tokyo, Japan)|July 26, 2022
Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistanceJing Zhu, Wenwen Wu, Yukiko Togashi, et al.
Pageof 18

Showing results (81-90 of 178) with videos related to

Sort By:
Pageof 18
Breast Cancer (Tokyo, Japan)|April 5, 2016
Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastasesArisa Nishimukai, Tomoko Higuchi, Hiromi Ozawa, et al.
EJNMMI Research|January 25, 2021
Preliminary study of AI-assisted diagnosis using FDG-PET/CT for axillary lymph node metastasis in patients with breast cancerZongyao Li, Kazuhiro Kitajima, Kenji Hirata, et al.
Journal of Surgical Oncology|June 25, 2018
High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapyYukie Fujimoto, Tomoko Higuchi, Arisa Nishimukai, et al.
Breast Cancer Research and Treatment|October 14, 2024
The cytokine profile correlates with less tumor-infiltrating lymphocytes in luminal A breast cancerEri Ishikawa, Takahiro Watanabe, Takako Kihara, et al.
Anticancer Research|May 23, 2002
uPA receptor expression in benign and malignant thyroid tumorsSeung Jin Kim, Eiichi Shiba, Tetsuya Taguchi, et al.
Anticancer Research|January 31, 2025
Clinical Utility of Sentinel Lymph Node Biopsy Using the Medical Imaging Projection System in Breast Cancer Patients, Including Those Following Neoadjuvant ChemotherapyAoi Oshiro, Masayuki Nagahashi, Yusa Togashi, et al.
European Journal of Radiology|December 21, 2022
Relationship between FDG-PET and the immune microenvironment in breast cancerKazuhiro Kitajima, Tomoko Higuchi, Yukie Fujimoto, et al.
Anticancer Research|July 5, 2020
C-Reactive Protein and Absolute Lymphocyte Count Can Predict Overall Survival of Patients Treated With EribulinAtsushi Sata, Reiko Fukui, Yoshimasa Miyagawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Prognostic significance of CD55 expression in breast cancerJun-Ichiro Ikeda, Eiichi Morii, Yalan Liu, et al.
Breast Cancer (Tokyo, Japan)|July 26, 2022
Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistanceJing Zhu, Wenwen Wu, Yukiko Togashi, et al.
Pageof 18